Quick answer

Evaluate a research peptide supplier by checking whether it provides batch-specific Certificates of Analysis, clearly identifies lot numbers, reports HPLC purity and LC-MS identity data where applicable, explains storage requirements, and gives researchers a way to connect the documentation to the physical product received. Transparent, traceable evidence is more useful than broad quality claims.

How to Evaluate a Research Peptide Supplier?

To test a reliable research peptide supplier, rely on verifiable facts rather than claims. Prioritize the documents like COA provided. A strong quality system connects the product label, batch number, test documents, storage advice, and your own records. Together, these details confirm that your product matches the specific batch tested.

This guide gives an educational framework for evaluating research materials and their documentation. It makes no medical claims and gives no dosing, administration or therapeutic guidance. Where a product-specific document or your laboratory’s SOP offers more specific direction, follow that first. 

There is a useful global benchmark for why documents beat claims: established Good Manufacturing Practice (GMP) standards (such as those referenced by the FDA in 21 CFR 211.84 and mirrored in UK/EU GMP guidelines) accept a supplier’s report of analysis only when the buyer also runs its own identity test and validates the supplier’s results over time. Evidence you can verify is the standard worth applying.

What Should You Check Before Choosing a Research Peptide Supplier?

Before choosing a research peptide supplier, check six areas: research-use, batch-specific COAs, HPLC purity data, LC-MS identity evidence, identifiable documentation sources, and clear product-storage and traceability information.

Here is the six-point checklist in full:

1. Research-use positioning: Does the supplier clearly describe the material as for laboratory research only?

2. Batch-specific COAs: Can documentation be matched to a unique lot or batch number?

3. HPLC documentation: Is the purity method and batch result clearly stated?

4. LC-MS documentation: Is mass-related identity evidence available where applicable?

5. Document traceability: Is the issuing laboratory or report source identifiable?

6. Storage and handling information: Are format-specific instructions available for the supplied product?

Treat the six as a set. A strong result on one point supports the others, and a gap on any single point is a prompt to ask the supplier for more detail before you decide.

Does the Supplier Provide Batch-Specific Peptide COAs?

A useful peptide COA should identify the specific batch or lot tested and let researchers match that number to the label on the physical product. A generic certificate with no batch identifier cannot reliably document the exact material you received.

What Is a Batch-Specific COA?

A COA is a document that reports analytical information for a specified material batch, such as PT-141. The lot or batch number is the field that connects the physical product to that report, so it turns a general certificate into evidence for one exact item. Keep the COA with your receipt and inventory records, so the document and the product stay together from the day they arrive.

How Do You Match a COA to a Peptide Product?

Work through a simple, repeatable process:

1. Locate the lot or batch number on the product label.

2. Find the lot or batch number listed on the COA.

3. Confirm the two identifiers match exactly.

4. Confirm the product name and format are consistent across both.

5. File the COA in your internal batch or inventory record.

For a fuller walkthrough of the document itself, read our guide on how to read a peptide Certificate of Analysis.

What If the Lot Number Does Not Match the COA?

If a product’s, like BPC-157, lot number does not match the COA, treat the document as unconfirmed for that item. Set the product aside in line with your laboratory procedures, then request batch-specific clarification before you assign it to any research. A mismatch is a question to resolve, and catching it early is the check doing its job.

How Do HPLC Results Help Verify Peptide Purity?

HPLC results help you assess the reported purity profile of a tested peptide batch by separating the detectable components in the sample. Review the stated HPLC result alongside the batch number, the method information, the test date, and the chromatogram where one is supplied.

What Does HPLC Show on a Peptide COA?

High-performance liquid chromatography separates the components within a test sample. It gives a reported result tied to the main component under the stated test method, so the figure carries meaning when the method sits next to it. Read purity figures together with the method and batch details. A purity percentage on its own is one useful data point within a broader verification process.

What Should HPLC Documentation Include?

HPLC item	Why it matters
Product name	Identifies the stated material
Lot/batch number	Links the test result to the physical product
Method or method reference	Shows how the result was generated
Reported purity result	Provides the stated batch-level result
Test/report date	Adds documentation context
Chromatogram, if available	Adds visual context to the separation result
Testing source	Supports document traceability

Is a High Purity Figure Enough on Its Own?

A reported purity figure is one part of a broader batch-verification process. Read it alongside product identity, lot matching, LC-MS information where available, and the product’s storage and handling record. Confident verification tends to draw on several lines of evidence at once, which is why a single number sits within a fuller picture.

How Does LC-MS Help Confirm Peptide Identity?

LC-MS combines chromatographic separation with mass-spectrometric analysis, and it can provide evidence that the tested material has mass-related characteristics consistent with the stated peptide identity. It complements HPLC because identity evidence and purity evidence answer different questions.

What Is the Difference Between HPLC and LC-MS?

Method	Main role	Question it helps answer
HPLC	Purity profile	What proportion of the tested sample is tied to the main component?
LC-MS	Identity support	Does observed mass-related data align with the stated peptide identity?
COA and batch check	Traceability	Does the analytical report relate to the exact product batch received?

Reading purity and identity together reflects how careful characterisation actually works. Research in *Pharmaceutical Research* (McCarthy and colleagues, 2023) explains that “this enhanced characterization often requires multiple orthogonal techniques to confidently understand, verify, and quantify the characteristics” of a peptide reference standard. In plain terms, more than one method, read side by side, builds a more confident picture than any single result.

What LC-MS Information Should Researchers Look For?

• Product or peptide name
• Batch or lot number
• Method or report reference
• Observed mass-related result
• Expected mass reference, where reported
• Test date or report date
• Testing laboratory or report issuer

Why Do Observed and Expected Mass Values Matter?

An expected molecular weight is a reference value, a number you can predict from the sequence. A batch-specific analytical report tells you more when it also identifies an observed result generated from testing the stated batch. When the observed value lines up with the expected one, the report is showing a real measurement from the stated batch, which a predicted value on its own cannot give you.

Can You Identify Who Produced the Peptide Test Documentation?

Research peptide documentation should identify the laboratory, analytical provider or report issuer responsible for the test record. Clear authorship, report identifiers and test dates make it easier to judge whether a document can be attributed to a specific batch.

What Makes Test Documentation Traceable?

• A named testing laboratory, report issuer, or responsible analytical source
• A report number, COA number, or document-control reference
• A test date and an issue date
• A named product with its batch or lot number
• An analytical method reference
• Clear, readable results

Why Is an Identifiable Report Source Important?

A named source tells researchers where a report came from, and it gives the supplier a clear point of contact for documentation questions. It forms one link in a transparent evidence chain, and it helps you separate batch-linked documentation from broad marketing statements. The aim is a document you can attribute and follow up, so questions about a batch have somewhere to go.

There is a wider principle at work here. Quality systems treat a supplier’s paperwork as a starting point that a buyer confirms over time. This approach aligns with established Good Manufacturing Practice (GMP) standards, including those referenced in UK and EU guidance, which emphasize that a supplier’s Certificate of Analysis is only reliable when the buyer periodically verifies the supplier’s results through their own independent identity testing. 

Applied to a research setting, the takeaway is simple. A named, attributable report gives you something to validate, while an anonymous certificate gives you very little to work with.

How Do You Verify a Peptide Product Label Against Its Documentation?

Verify a peptide product label by matching the product name, the research format, the lot number, the relevant stated concentration or strength, and the storage instructions against the order documentation and the associated COA.

Field	Physical product label	Supporting documentation	What should match
Product name	Label on pen or vial	COA and order record	Clear product identity
Format	Reconstituted vial or research pen	Product description or record	Same stated presentation
Lot/batch number	Product label	COA	Exact match
Concentration/strength	Product label where stated	Product record or COA where shown	No unexplained difference
Storage instruction	Packaging or product document	Storage guide or product documentation	Same relevant handling direction
COA reference	Batch file	Controlled document record	Clear traceability link

What Should You Do If the Label Is Unclear?

If a label is damaged, incomplete or inconsistent with the associated documentation, record the issue and seek clarification before you add the product to an active research workflow. A short note now keeps your records clean and your batch traceable later.

What Storage and Handling Information Should a Research Peptide Supplier Provide?

A research peptide supplier should provide product-specific storage and handling information that reflects the supplied presentation, whether that is a reconstituted vial or a pre-filled research pen. Follow the product label, the accompanying documentation and your laboratory SOP, and rely on those ahead of generic online shelf-life claims.

What Should a Storage Instruction Cover?

• Product format and presentation
• Temperature or controlled-storage requirement
• Light-protection guidance where applicable
• Container-handling requirements
• Guidance for delivery receipt and prompt storage
• The relevant batch or documentation reference
• A clear instruction to follow product-specific information

Why Does Reconstituted Format Need Product-Specific Guidance?

Reconstituted products arrive as prepared solutions, so their handling begins at receipt, with storage control and documentation from day one. The right storage conditions depend on the specific product formulation and the supplied instructions, which is why product-specific guidance carries more weight than a general rule. For a deeper look, read our guide on reconstituted peptide storage and handling for research.

How Do Research Peptide Pens and Vials Affect Supplier Evaluation?

Peptide pens and vials can change the practical research workflow, and both formats should be evaluated with the same quality-documentation controls: clear labels, batch-specific COAs, analytical evidence, product-specific storage instructions and traceable inventory records.

Supplier-evaluation factor	Pre-filled research pen	Reconstituted research vial
Product presentation	Prepared solution in a controlled pen format	Prepared solution in a vial format
Documentation check	Match label and lot number to COA	Match label and lot number to COA
Storage requirement	Follow product-specific information	Follow product-specific information
Batch record	Log receipt, location and condition	Log receipt, location and condition
Core standard	Traceable documentation	Traceable documentation

Does Format Change Batch-Verification Standards?

Product format affects the handling workflow at the bench, and it keeps the need for lot-level traceability and evidence-based documentation exactly the same. For a fuller comparison, see our guide on peptide pens vs vials for research.

What Are the Main Red Flags When Choosing a Research Peptide Supplier?

The main supplier-evaluation red flags are missing batch identifiers, documentation that cannot be connected to a physical product, unexplained label discrepancies, missing analytical method details, and unclear storage or report-source information.

Red flag	Why it requires clarification	Responsible next step
No batch or lot number on the COA	Cannot link the document to a physical product	Request batch-specific documentation
Lot number differs from product label	May indicate the COA is for a different item	Set aside and request clarification
No HPLC method or result context	Purity claim lacks an analytical basis	Request the supporting analytical information
Only expected mass information	May not show observed batch testing	Request LC-MS evidence where relevant
Testing source is unclear	Report origin cannot be assessed	Ask who generated or issued the documentation
Product label is incomplete	Weakens traceability	Record the issue and seek confirmation
No storage information	Prevents controlled handling	Request product-specific instructions
Outcome-heavy claims with little documentation	Shifts attention away from verifiable evidence	Prioritise documents and traceability

A single red flag does not condemn a supplier. It marks a point that deserves a clear answer, and how readily a supplier provides that answer is itself useful evidence. 

• A supplier who returns a batch-specific COA, names the testing source and explains the method within a reasonable time is showing you a working documentation system. 
• Slow, vague or deflecting replies to a straightforward batch question tell you something too, and they are worth noting in your evaluation record alongside the documents themselves.

What Is Our Six-Point Supplier Documentation Check?

Our Six-Point Supplier Documentation Check is a research-focused framework for reviewing whether a supplier gives enough information to verify a product batch before research use.

1. Research-use clarity: Is the material clearly presented for laboratory research use?

2. Product identity: Does the label clearly identify the product and presentation?

3. Batch traceability: Is there a unique lot number that can be matched to the COA?

4. Purity evidence: Is batch-specific HPLC documentation provided?

5. Identity evidence: Is LC-MS or relevant mass documentation provided where applicable?

6. Handling documentation: Are storage, receipt and traceability instructions clear?

A supplier is best judged by the quality and traceability of the documentation researchers can review, and clear evidence carries more weight than a broad quality claim.

How Should Researchers Document a Supplier Evaluation?

Researchers can document a supplier evaluation by recording the supplier name, the product, the batch number, the COA reference, the analytical-document status, the storage instructions, and any clarification requests before assigning materials to a research workflow.

Record field	Example purpose
Supplier name	Identifies the source reviewed
Product name and format	Identifies the research material
Lot/batch number	Links the physical item to documentation
COA reference	Retains the analytical report
HPLC review status	Records whether purity documentation was reviewed
LC-MS review status	Records identity-document review where applicable
Storage instruction	Documents supplied handling requirements
Date reviewed	Creates an auditable review point
Reviewer initials	Identifies who completed the check
Notes or clarification request	Records unresolved document issues

Once a batch is on your shelf, the next step is confirming it item by item. Our guide on how to verify a research peptide batch covers the COA, HPLC and LC-MS checklist in detail.

Frequently Asked Questions About Research Peptide Suppliers

What Should a Research Peptide Supplier Provide?

A research peptide supplier should provide product-specific information and documentation that lets researchers verify product identity, batch traceability, analytical results and handling requirements. The clearer and more traceable that evidence is, the easier the supplier is to evaluate.

Is a Certificate of Analysis Enough to Evaluate a Peptide Supplier?

A COA is an important part of supplier evaluation. Read it together with the physical label, the lot number, HPLC and LC-MS data where applicable, the storage information, and the supplier’s ability to explain the documentation.

How Can I Tell Whether a Peptide COA Is Batch-Specific?

Look for a unique lot or batch number on the COA, then confirm it matches the exact lot number printed on the physical product label. That match is what ties the report to your specific item.

Why Are Both HPLC and LC-MS Relevant?

HPLC provides reported purity information for a tested batch, while LC-MS can provide mass-related evidence consistent with the stated peptide identity. Read together, they support a broader verification process than either gives alone.

What Should I Do If the COA Lot Number Does Not Match the Product Label?

Treat the COA as unconfirmed for that product. Record the discrepancy and request batch-specific clarification before you assign the product to research.

Do Pre-filled Peptide Pens and Vials Need the Same Documentation?

Yes, both formats should carry clear labels, batch-specific documentation, relevant analytical evidence and product-specific storage information.

Can Generic Online Storage Rules Replace the Supplier’s Instructions?

Follow the specific product label, the supplied documentation and your laboratory’s SOP, because storage needs can vary by product format and formulation. Treat general online rules as background only.

Conclusion

Choosing a research peptide vendor should begin with evidence you can check: an identifiable product, a matching batch number, a batch-specific COA, clear analytical documentation and product-specific handling information. A traceable documentation process helps researchers build a more controlled workflow, from supplier selection through batch receipt and storage.

Take a look at our research peptides and review the relevant product information and batch documentation before assigning material to a research workflow.

Quick answer

To verify a research peptide batch, match the product label and lot number to its Certificate of Analysis, review the batch-specific HPLC purity and LC-MS identity evidence, confirm the documentation is complete and attributable, then record the item in the laboratory inventory. A COA should always be reviewed alongside the physical product it represents.

How to Verify a Research Peptide Batch?

A product claim on its own does not establish research quality. Quality comes from documentation you can link back to the exact batch in your hands. That link, from the physical item to its paperwork, is the whole point of batch verification.

A practical check has a few clear steps. You confirm the product label, match the batch or lot number, review the COA, look over the analytical methods behind the results, and log the item in your own records. Each step connects one piece of evidence to the next.

This guide is written for research-material documentation and quality-control workflow. It does not give medical advice, dosing information, administration guidance, or any clinical claim. Where product-specific instructions, the supplied documentation, or your laboratory’s SOP say something different from this general guide, those take priority every time.

Before you review a batch, it helps to understand the document itself, so it is worth getting familiar with how to read a peptide Certificate of Analysis first.

What Is Research Peptide Batch Verification?

Research peptide batch verification is the process of confirming that the physical peptide product, its label, its lot or batch number, and its analytical documentation all refer to the same identifiable material. It helps researchers keep traceability before material is assigned to a research workflow.

A batch, or lot, is one identifiable unit of production or supply. The batch number is the thread that ties a pen or vial to its COA and to your inventory record. Follow that thread and every piece of paper points back to the same physical item.

Verification covers more than purity. A good check also confirms product identity, shows that the document actually belongs to this product, records how and when the item arrived, and keeps storage accountable. Purity is one field on the page among several that carry weight.

There is one firm rule to carry through the rest of this guide. A COA that does not match the physical product, exactly, should not be treated as supporting documentation for that product.

Core principle: No matching lot number means no confirmed link between the document and the product.

The Apexion Five-Point Batch Verification Check

The Apexion Five-Point Batch Verification Check gives researchers a simple process for confirming product identity, batch documentation, analytical evidence and traceability before research use.

Check	Question to ask	Evidence to review
1. Product identity	Does the product name and format match the order?	Product label, order record, packaging
2. Batch identity	Does the lot number exactly match the COA?	Product label and COA
3. Purity evidence	Is batch-specific HPLC information available?	COA, HPLC result, chromatogram where supplied
4. Identity evidence	Is LC-MS or mass-confirmation evidence provided where applicable?	COA, LC-MS result, mass data
5. Traceability	Has the item been logged and assigned to controlled storage?	Inventory record, receipt log, storage record

This five-point check works alongside product-specific instructions and your own quality procedures, and defers to them where they differ. Think of it as a simple frame for connecting the supplied product to its documentation and your internal research records.

How Do You Match a Peptide Label to a COA?

Match the exact lot or batch number printed on the physical peptide label to the lot or batch number on the Certificate of Analysis. The product name, the presentation and any relevant label details should also line up with the documentation.

Check the product name

The product name on the physical pen or vial should agree with the name on the COA. Watch for small naming differences that point to a different presentation, concentration, blend, or product version. A little formatting variation can happen, yet the underlying product identity should stay clear at a glance. 

If you are matching a multi-compound label, take extra care: a blend such as CJC-1295 with no DAC + Ipamorelin 10mg names two compounds, and both should read consistently across the label, order record and COA.

Match the batch or lot number exactly

The lot number is the single most important traceability field. It should match character for character wherever possible. A similarly named COA still belongs to a different item if the batch number differs, so treat each one on its own. 

Where a batch and its paperwork do not agree, record the discrepancy before the product is assigned to any work. The same discipline applies to any single-compound item, for example a BPC-157, where one label maps to one COA.

Confirm the product presentation

Field	What to check
Product format	Reconstituted research vial or pre-filled research pen
Product name	Consistent on label, order record and COA
Batch/lot number	Exact match between physical product and COA
Strength or concentration	Match where displayed on both records
Quantity or presentation	No unexplained difference from the order
Storage instruction	Consistent with supplied product guidance
COA document reference	Retained in the batch inventory record

What if the lot number does not match?

If the product lot number and the COA lot number are different, do not treat that COA as documentation for the item. Set the product aside under your laboratory’s quality process, then request clarification with the relevant product and document details to hand. A mismatch is a prompt to pause and ask, and the check has done its job by catching it.

How Do You Check HPLC Purity on a Peptide COA?

HPLC information on a peptide COA shows the reported purity profile of the tested batch. Review the batch number, the stated method, the reported purity result, the test date, and the supporting chromatogram where one is supplied.

What HPLC tells you

High-performance liquid chromatography separates the components in a sample. The output helps you see the share tied to the main peptide component against other detectable components. Read the reported percentage as one part of a complete, batch-specific analytical record, and let it sit in context with the rest of the page. Purity is one field on the page among several that matter.

What to look for on the COA

• Clearly stated peptide or material name
• Exact batch or lot number
• HPLC method or method reference
• Reported purity value
• Test date or report date
• Testing laboratory or report issuer
• Chromatogram, if supplied
• A clear connection between the report and the physical batch

Why a Chromatogram Can Add Context

A chromatogram gives you a visual read of the separation result. It adds useful context beyond a single purity percentage, and it can show how clean the separation looks. Read it against the stated method and the supplier documentation. A chromatogram supports the purity picture, though molecular identity is confirmed elsewhere, and that is where LC-MS evidence becomes relevant.

For a fuller explanation of chromatograms, purity figures and analytical terms, see our guide on how to read a peptide Certificate of Analysis, which covers HPLC, LC-MS, purity and batch verification in more depth.

How Does LC-MS Help Verify Peptide Identity?

LC-MS supports peptide identity verification by pairing chromatographic separation with mass-spectrometric measurement. Researchers should look for batch-linked observed mass information that agrees with the stated peptide identity.

HPLC and LC-MS have different roles

Analytical method	Main verification role	Key question it helps answer
HPLC	Purity and sample composition	What share of the tested sample is tied to the main component?
LC-MS	Identity support through mass evidence	Is the observed mass-related result consistent with the stated peptide?
COA review	Batch-level documentation	Does this analytical information relate to the physical lot received?

The two methods answer different questions and read best together. Work published in *The AAPS Journal* (Zeng and colleagues, 2015) notes that combined liquid chromatography and high-resolution mass spectrometry “are capable of detecting and identifying co-eluting impurities at low levels,” which is context an HPLC purity figure alone may not surface. Reviewing both is how you build a fuller documentation check, and it pairs naturally with a well-documented item such as a Tesamorelin, where the COA carries both result types.

What to look for in LC-MS documentation

• Product or peptide name
• Batch or lot number
• Method reference, if included
• Observed mass-related result
• Expected mass reference, where reported
• A clear test date or report date
• Testing source or laboratory reference

Avoid confusing expected data with observed data

An expected molecular weight is a reference value, a number you would predict from the sequence. Stronger identity documentation shows the actual observed result from testing and links that result to the specific product batch. 

The same paper explains why the observed figure carries weight: “changes to the primary amino acid sequence due to degradation, truncation, insertion, substitution, or deletions typically result in detectable mass shifts.” An observed mass that lines up with the expected value is doing real work.

Why purity and identity should be reviewed together

A purity result on its own does not confirm exact molecular identity. A mass result on its own does not explain the full purity profile. Read both together, next to the batch number, and you get a more complete documentation check than either gives alone. This matters for identity-led compounds such as GHK-Cu, where the observed mass supports the stated peptide.

What Should a Complete Peptide COA Include?

A complete peptide COA should let you identify the tested material, connect it to a specific batch, understand the analytical methods used, and read the reported results in context. Each field earns its place by answering one of those needs.

COA field	Why it matters
Product or peptide name	Identifies the stated material
Batch or lot number	Connects the COA to the physical product
COA or report number	Supports document control
Issue date or test date	Provides document timing context
HPLC result	Provides batch-specific purity information
HPLC method reference	Clarifies the analytical basis
LC-MS or mass data	Supports peptide identity verification where applicable
Observed versus expected values	Helps separate test results from reference values
Testing laboratory or issuer	Shows who generated or issued the documentation
Signature, approval or report-control information	Supports document traceability where available

What a COA can confirm

• Batch-linked analytical information
• Reported purity data
• Identity-supporting mass information where included
• The testing or documentation source
• Batch-specific quality documentation at the time of testing

What a COA cannot confirm by itself

• Storage conditions after delivery
• Internal laboratory handling after receipt
• Whether the material was assigned to the correct research protocol
• Whether a label was later damaged, changed, or separated from the batch
• Whether generic online storage claims apply to that specific product

How Should You Document a Research Peptide Batch?

Document a research peptide batch by creating an inventory record that links the physical item, its batch number, COA, receipt condition, storage location and any relevant handling events. One record, one batch, all the details in a single place.

Good records also reflect a wider quality principle. The ICH Q7 GMP guideline states that “a system should be in place by which the distribution of each batch … can be readily determined to permit its recall.” Your inventory record is the lab-side version of that idea: it keeps each batch findable long after it arrives.

Minimum batch-record template

Record field	What to document
Internal sample ID	Unique laboratory inventory identifier
Product name	Full product name on the label
Product presentation	Pre-filled research pen or reconstituted vial
Batch or lot number	Exact identifier from the product
COA reference	COA number, file name or controlled location
Date received	Date material entered laboratory control
Received by	Name or initials of the responsible person
Condition at receipt	Package, label and container condition
Storage instruction	Product-specific stated condition
Storage location	Unit, shelf, cabinet or controlled location
Handling event	Any movement, issue or noted deviation
Research record reference	Optional internal study, assay or protocol ID

Why storage records matter for reconstituted peptide products

Reconstituted products arrive in a prepared solution format, which can simplify your workflow by removing a separate in-lab reconstitution stage. That convenience still sits alongside controlled storage and batch traceability, both of which stay just as important. The storage record builds a post-receipt history for the same batch named on the COA, so the paper trail continues past the front door. Clear records also keep results consistent across researchers, research sessions and inventory checks. A format such as MOTS-c benefits from a storage line in the record from the day it arrives.

For storage-focused guidance, read our guide on reconstituted peptide storage and handling for research, which covers stability, temperature and batch documentation.

What Are the Red Flags on a Peptide COA?

A peptide COA may need clarification when it cannot be reliably connected to the physical product, lacks basic analytical detail, or includes information that is incomplete, inconsistent or hard to attribute to a specific batch.

Potential red flag	Why it matters	Appropriate next step
Lot number does not match the label	The COA may relate to a different item	Set aside the product and request clarification
No lot or batch identifier	The document cannot be tied to a physical product	Ask for batch-specific documentation
Product name is unclear or inconsistent	Material identity may be uncertain	Verify product and document details
Purity figure lacks method context	The analytical basis is unclear	Request the method or supporting report
Only expected mass is listed	Reference data may appear without observed test data	Request batch-linked LC-MS evidence
Testing source is not identified	The document is hard to attribute	Request laboratory or report-issuer information
Label is damaged or incomplete	Product-to-document traceability may be affected	Record the issue and seek clarification
Storage instruction is missing	Controlled handling is harder to plan	Obtain product-specific guidance before use

A red flag does not prove a product is unsuitable on its own. It signals that further batch-specific clarification is worth having before the material is assigned to a research workflow. Ask the question, get the answer, then decide.

How Do Pre-Reconstituted Pens and Vials Affect Batch Verification?

Pre-reconstituted peptide pens and vials can simplify research handling by supplying the product in solution. The same batch-verification controls still apply: product-label review, lot-to-COA matching, storage confirmation and inventory documentation.

Verification principles remain the same

Verification point	Pre-filled research pen	Reconstituted research vial
Product identity	Confirm product name and presentation	Confirm product name and presentation
Batch check	Match pen label to COA lot number	Match vial label to COA lot number
Analytical documentation	Review HPLC and LC-MS data where provided	Review HPLC and LC-MS data where provided
Storage record	Log product-specific storage location	Log product-specific storage location
Handling record	Document relevant movement or deviations	Document relevant movement or deviations

The format changes the workflow, standards stay the same

The format changes how a research product is handled at the bench. It keeps every documentation standard in place: transparent paperwork, batch-level evidence and controlled storage records stay the same across both presentations. Learn more about format differences in our peptide pens vs vials for research comparison.

How to Use This Guide Responsibly

This guide sets out a general framework for verifying research-material documentation. Product labels, batch COAs, supplied handling instructions and laboratory SOPs take priority wherever they carry more specific information.

• Read analytical data within the limits of the reported method.
• Treat batch documentation as support for a quality workflow, and keep protocol design, laboratory controls and research-method validation as separate responsibilities.
• Rely on product-specific documentation for shelf-life questions, ahead of generic online claims.
• Record any storage, packaging, labelling or document issue before the material moves into active research.

Clear, honest documentation is what search engines and AI answer systems reward too, because it stays accurate and genuinely useful. For a related compound comparison, our BPC-157 vs TB-500 research overview shows how identity and documentation questions play out across two specific peptides.

Frequently Asked Questions

How do I match a peptide COA to a vial or pen?

Match the exact batch or lot number on the physical product to the lot number listed on the COA. Then confirm that the product name, format and any relevant stated details are consistent across both.

What is the difference between HPLC purity and LC-MS identity verification?

HPLC reports the purity profile of a tested batch, showing the share tied to the main component. LC-MS provides mass-related evidence that supports peptide identity. Reading both together gives a more complete documentation check.

Can a COA confirm how a peptide was stored after delivery?

No, a COA carries analytical information tied to the tested batch. A receiving record and a storage log document the product after it enters laboratory control, which is where post-delivery history lives.

What should I do if a peptide lot number does not match the COA?

Do not treat that COA as documentation for the item. Set the product aside under your quality process, then request batch-specific clarification before any research use.

Should a peptide COA include a chromatogram?

Where supplied, a chromatogram adds useful context to a reported HPLC purity result. The key requirement is that the analytical information links clearly to the relevant batch.

Do pre-reconstituted peptide products still need batch verification?

Yes, a pre-reconstituted presentation simplifies the workflow, and it keeps the need to verify the physical label, lot number, COA and storage documentation fully in place.

What should be included in a peptide batch record?

Include the product name, format, lot number, COA reference, date received, receipt condition, storage instruction, storage location, responsible person, and any relevant handling or deviation notes.

Conclusion

Reliable research peptide documentation rests on one simple idea: the product, the batch number, the COA and the inventory record should all point to the same identifiable material. Review the lot-level analytical evidence, confirm that the label and COA line up, and keep a controlled storage record. Do that on every batch and your workflow becomes clearer, more consistent and easier to trace.

Browse our research peptides and review the relevant batch documentation and product-specific handling information before assigning material to a research workflow.

Reconstituted research peptides arrive as prepared solutions, so your laboratory can skip the extra handling of preparing a peptide from dry material. 

• Treat storage and handling as part of a controlled research workflow. 
• Verify the batch documentation on arrival, follow the supplied storage conditions, keep the material within its stated temperature range, protect the container from avoidable light and unnecessary handling, and keep a clear record from receipt through to research use. 

Knowing how to store reconstituted peptides really comes down to two things working together: stable conditions, and paperwork that ties every step back to a specific batch. This guide walks through both.

Note: This article covers research material handling and documentation only. It does not provide clinical, dosing or administration guidance.

What Is a Reconstituted Research Peptide?

A reconstituted peptide is a peptide supplied in solution, in place of a dry, lyophilised cake or powder. The material is already in a prepared form when it reaches your bench.

The formulation behind that solution can include a selected solvent, a buffer, excipients, a defined concentration, a primary container and a closure system. Each of these is part of the product design, and each can affect how the solution behaves over time.

Stability in solution is not set by the peptide identity alone. It can depend on the formulation and packaging design, the temperature history, light exposure, the solution chemistry and the way the material is handled. Two products with the same named peptide can hold different storage requirements if their formulation and container differ.

Because of that, the product-specific handling instructions are your primary source of guidance. The general principles in this article support those instructions; they never replace them. When a product label or accompanying document states a condition, that stated condition wins.

Why Pre-Reconstituted Format Supports Research Workflow Consistency

A pre-reconstituted format, such as pre-filled pens, can support consistency across a research workflow, because the material arrives prepared and ready to log. The benefit lies in fewer preparation-stage variables and a cleaner documentation trail, and it holds only when you still follow the supplied storage and handling information.

Fewer preparation-stage variables

Researchers receive the material in a prepared format, like peptide pens. This can reduce the variation that creeps in when different people prepare concentrations independently, each with slightly different techniques.

It also removes the step of selecting and introducing a solvent as part of your initial handling. One fewer decision at the start means one fewer place for variation to enter a study.

Reduced initial material handling

Fewer handling stages can simplify sample receipt and inventory. There is less to do between the parcel arriving and the material sitting safely in controlled storage.

A sealed, supplied presentation can also support a clearer chain of custody. The container you log is the container you store, with no intermediate transfer to record.

More consistent documentation workflow

At receipt, you can connect the batch number, the presentation, the supplied concentration and the Certificate of Analysis in one record. Everything the batch needs travels together from the first entry.

The laboratory can then create a sample record without also documenting a separate internal reconstitution event. That keeps the batch documentation shorter and easier to audit later.

Format-specific research planning

Pens and vials can support different workflow needs. A pre-filled research pen suits workflows that value measured, repeatable handling, while a vial suits processes built around vial-based laboratory steps. For a fuller breakdown, see our guide on peptide pens vs vials for research, which notes that the two formats can hold the same peptide while differing in delivery and operator-handling characteristics.

A prepared format can support and may simplify your workflow. It does not automatically improve purity, accuracy, research outcomes or assay performance. Those still depend on the compound, the method and the conditions you maintain.

Reconstituted Peptide Stability: What Influences It?

Peptide stability in solution is influenced by temperature, light, container integrity, handling frequency and freeze-thaw exposure. Temperature is usually the largest single factor, and the practical goal is simple: keep the product within its stated conditions and limit avoidable stress. The table below summarises the factors, and they are expanded underneath.

Stability factor	Why it matters	Practical control
Temperature	Warmer conditions speed up degradation reactions	Hold the stated range; store promptly
Light exposure	Some formulations are light-sensitive	Keep material in its supplied packaging
Container closure	Open or damaged containers risk contamination and moisture	Keep sealed; log any damage
Handling frequency	Each access adds time out of storage	Plan access; avoid repeated checks
Freeze-thaw	Repeated cycling can accelerate breakdown	Follow the product and SOP instructions

Temperature control

Temperature and temperature swings can change how quickly a peptide solution degrades. As a rule of thumb from reaction kinetics, hydrolysis rates roughly double for every 10°C rise, which is why warm conditions are the main risk to a solution.

• Keep the product at the temperature stated on its label or accompanying documentation. 
• Store it promptly after delivery, and avoid unnecessary time outside the specified range. 
• Keep it away from the temperature-unstable spots in a fridge or freezer, such as the door shelves, where the temperature shifts every time the unit is opened. 
• Record any significant temperature excursion through your established quality process. 

According to AAPPTEC, peptide solutions may hold for several days at room temperature, several weeks at around 4°C and several months at -20°C, though the exact figures depend on the specific peptide and formulation. Treat that as background, and follow the product documentation for laboratory peptide storage conditions in every case.

Light exposure

Certain peptides and formulations can be light-sensitive. Where that applies, bright light during receipt or set-up can add avoidable stress.

Keep peptide pens in their original packaging, or in the secondary protective packaging where it is provided. Avoid prolonged bright-light exposure while you receive, inventory or set up the material. This is a formulation- and product-specific consideration, so treat light protection as a sensible default and check the product information for anything more specific.

Container closure and product integrity

Keep the container securely closed whenever it is not being accessed under the applicable research procedure. A closed container holds the solution chemistry the formulation was designed around.

Avoid transferring material between containers unless your research protocol requires it. Original containers support label retention, batch traceability and clear product identification, and a transfer puts all three at risk. Record any compromised seal, container damage or label inconsistency as a deviation, and review it before the material goes any further.

Handling frequency

Limit unnecessary movement, prolonged time at ambient temperature and avoidable container access. Every extra handling event is another moment the material spends outside its ideal conditions.

Build research schedules around planned access, so you take out what a session needs in one go. Repeated checks add up. A simple, documented handling workflow can reduce preventable variability across a study, and it makes the storage log easier to keep honest.

Sigma-Aldrich advises letting a cold container equilibrate to room temperature before opening the lid, which reduces the moisture that can otherwise condense inside on contact with cold material.

Freeze-thaw control

Where the supplied product instructions or your laboratory SOP specify frozen storage, plan access to reduce unnecessary temperature cycling. Repeated freeze-thaw exposure can be a real stability consideration for peptide solutions, because each cycle adds physical and chemical stress. Sigma-Aldrich notes that freeze-thaw cycling should be avoided, as it accelerates degradation of the peptide.

For research peptides in vials, some laboratories address this by making working aliquots from a stock, where the product instructions and SOP allow it. For a product supplied as a ready-to-use, pre-filled pens or other formats, use it as supplied and follow the manufacturer’s handling instructions. The right control depends on the actual product presentation, so match the method to the format in front of you.

Receiving a Reconstituted Peptide Batch

A structured receiving step turns a delivery into a documented, traceable item of inventory. Do it before the material joins your working stock, so every later record has a clean starting point.

Receipt and verification checklist

Work through these on arrival, and record the result:

1. Confirm the product name, presentation and stated concentration or strength.
2. Check that the physical label matches the order record.
3. Match the batch or lot number on the product to the Certificate of Analysis.
4. Confirm that the package and primary container are intact.
5. Review any supplied storage and handling information before placing the item into inventory.
6. Record the receipt date, the receiver’s name or initials, the batch number and the storage location.
7. Note any concern about packaging condition, an unexpected delay or possible temperature exposure.
8. Store the material promptly according to its product-specific documentation.
9. Retain the COA and the receiving record within the same batch file.

Before you assign a product to a research workflow, review the lot-linked analytical documentation. Our guide on how to read a peptide certificate of analysis walks through the HPLC, LC-MS, purity and batch-verification detail in full. A COA establishes analytical documentation for a particular batch, while your receiving and storage records document the product after it enters the research environment. The two are partners: one describes the material, the other describes its custody.

Reconstituted Peptide Storage Log Template

A storage log is the single most useful document for day-to-day traceability, because it ties a physical item to a batch, a location and a handler. Use the framework below as a copyable on-page template, and adapt the fields to your own inventory system.

Record field	What to record
Internal sample ID	Your laboratory’s unique inventory identifier
Product name	The full research-product name
Format	Pre-reconstituted vial or pre-filled research pen
Batch or lot number	The exact number on the physical product
COA reference	File name, document number or internal location
Date received	When the laboratory accepted the product
Storage instruction	The product-specific stated condition
Storage location	Fridge or freezer unit, shelf or controlled cabinet reference
Handler	The person responsible for receipt or movement
Condition at receipt	Packaging, label and container observations
Deviation record	Any unexpected event or concern
Research-protocol reference	Optional link to the relevant internal study or assay record

Kept up to date, this log answers the questions an audit or a repeat experiment will ask: what is it, which batch, where has it been, and who handled it.

Batch Verification and COA Traceability

Batch verification confirms that the documentation in front of you belongs to the exact material you are holding. It is a quick check with a big payoff, because a mismatched record undermines every result that follows.

What to match before research use

Confirm each of these lines up across the product and its paperwork:

• Product name
• Batch or lot number
• Product presentation
• Stated concentration or strength, where provided
• Date of analysis or release information
• HPLC purity data, where present
• LC-MS or molecular-mass identity information, where present

Why the COA and storage log work together

The Certificate of Analysis and the storage log do different jobs, and a complete record needs both. One documents the material’s analysis; the other documents its life inside your laboratory.

Document	Primary purpose
Certificate of Analysis	Batch-associated analytical and identity documentation
Product label	Identifies the physical item, format and batch
Receiving record	Documents the material entering laboratory control
Storage log	Shows assigned storage and temperature-management history
Deviation record	Captures unexpected events requiring review
Research record	Links the identified batch to a specific study or assay

What to do if the batch number does not match

Avoid assuming the documents belong to the product when the numbers disagree. Set the material aside or quarantine it according to your laboratory process. Contact the supplier with the product and document details so they can confirm the correct batch record. Record the issue within your internal quality or inventory system, so the resolution is documented alongside the batch.

Pens and Vials: Handling Differences in Reconstituted Formats

Both formats supply a prepared solution, and both call for the same care over storage, traceability and documented handling. The format changes the workflow around the material, and it leaves the core principles untouched.

Consideration	Pre-filled research pen	Reconstituted vial
Presentation	Prepared solution in a controlled pen format	Prepared solution in a vial
Research workflow	May support measured, repeatable format handling	May support workflows built around vial-based steps
Key verification	Product label, batch number, COA, storage instructions	Product label, batch number, COA, storage instructions
Shared principle	Follow the exact product handling requirements	Follow the exact product handling requirements

The format you choose shapes how you handle the material. It does nothing to reduce the importance of storage, traceability and documented handling. For the full comparison, see peptide pens vs vials for research, and match the format to the way your research is planned.

Common Handling Mistakes to Avoid

Most storage problems come from a handful of avoidable habits. The table pairs each one with a simple research control.

Avoidable issue	Better research control
Using generic online storage durations	Follow the supplied product documentation and your internal SOP
Separating a product from its COA	Keep a lot-to-COA link in the inventory record
Moving product repeatedly between locations	Assign a stable, documented storage location
Leaving the product outside controlled storage longer than needed	Plan receipt, inventory and research workflows before access
Ignoring damaged packaging or unclear labels	Record the concern and request verification before use
Treating every peptide solution identically	Consider the product’s particular formulation, presentation and instructions
Failing to log an excursion or handling event	Create a deviation record and review it through quality procedures

One more worth naming: stability is sequence-dependent. Sigma-Aldrich notes that peptides containing methionine, cysteine and tryptophan are prone to oxidation, and those with asparagine and glutamine to deamidation, which is why a blanket storage rule for every compound is a mistake. Let the product documentation, and the compound itself, set the conditions.

Reconstituted Peptide Handling FAQs

Are pre-reconstituted research peptides ready for laboratory workflow?

They are supplied in solution, which can reduce the need for an internal reconstitution step. Laboratories should still verify the batch documentation and follow the supplied storage and handling information before research use. The prepared format saves a step; it does not remove the need for careful handling.

Do all reconstituted peptide solutions have the same storage requirements?

No, requirements can vary with the peptide, the concentration, the formulation, the primary container, the closure system and supplier-specific stability information. Always read the product documentation, because two similar-looking products can carry different storage conditions.

How long do reconstituted peptides last, and is there a set shelf life?

There is no single answer. A reconstituted peptide shelf life depends on the compound, the formulation and the storage conditions, so the reliable sources are the product label, supplier documentation, batch information and your laboratory SOP.

Why is cold-chain handling important for peptide solutions?

Temperature influences solution stability, and warmer conditions speed up degradation reactions. Prompt storage and sticking to the product-specified temperature range help maintain a controlled handling history, which supports both stability and clean documentation.

Does the COA replace storage documentation?

No. The Certificate of Analysis gives batch-associated analytical information about the material. A receiving record and a storage log document the product’s status after your laboratory takes custody, so you need both for full traceability.

What should I do if I notice a storage or packaging issue?

Follow your laboratory’s deviation or quality procedure, preserve the relevant batch details and contact the supplier for batch-specific clarification before assigning the material to research use. Recording the issue matters as much as resolving it.

Browse Research Peptides With Clear Documentation

Good reconstituted peptide storage comes down to steady conditions and records that trace back to a specific batch. Keep the two in step, and your research rests on material you can account for from receipt onward. To go deeper on a specific pairing, see our BPC-157 vs TB-500 research overview. When you are ready, browse research peptides from our catalogue and review the product-specific batch documentation and handling information for each compound.

A peptide Certificate of Analysis (COA) is a batch-specific analytical record. To assess it, first match the lot number to the supplied material, then review the HPLC chromatogram and purity result, compare the expected and observed mass in the LC-MS data, and check whether the report names the method, laboratory and test date. A COA supports quality documentation, but it does not automatically prove potency, sterility or suitability for any particular use.

Why a purity number is not enough

A COA is evidence attached to one specific tested batch. Read it that way, and a single headline figure stops carrying the whole story.

The same “99% pure” claim means very different things depending on what sits behind it. A percentage that arrives with no stated method, chromatogram, mass-spectrometry result or laboratory name is a marketing line. The same percentage backed by a dated chromatogram, an observed mass and a named lab is documentation you can actually check.

HPLC and LC-MS do two different jobs, and you need both. HPLC (high-performance liquid chromatography) separates the components in a sample and estimates chromatographic purity. LC-MS (liquid chromatography paired with mass spectrometry) measures mass data that supports identity, which tells you whether the main component is the peptide you ordered. Purity answers “how much of the signal is one thing.” Identity answers “is that thing the right thing.” One without the other leaves a gap.

This guide walks through reading a COA for research materials only. A peptide purity test by HPLC is only one part of that picture, and we test every batch by HPLC in-house and publish the result, so the aim here is simple: help you read any COA, ours or anyone’s, with a clear eye. If you want to see how we document a live batch, our high-purity research peptides pages show the format.

What Is a Peptide Certificate of Analysis?

A peptide Certificate of Analysis is a document that reports analytical findings for a defined peptide batch. It commonly lists the product identity, the batch or lot number, the test methods used, the reported purity, mass-spectrometry findings, the test dates and the laboratory details. Its value depends on whether those records trace back to the exact material in front of you.

What a peptide COA may confirm

• The name and stated identity of the tested peptide.
• The link to a specific lot or batch.
• The reported HPLC purity under the stated analytical method.
• Mass-based identity evidence from LC-MS or MS.
• Selected extra results, but only when they are specifically reported with data.

What a peptide COA does not automatically confirm

• Biological activity or potency.
• Net peptide content, unless a suitable quantitative content or assay result is stated.
• Sterility, endotoxin status, microbial condition or residual-solvent status, unless actual method-specific results are included.
• Stability after the report’s test date.
• Human suitability, safety, dosing or any therapeutic outcome.

Keep five ideas separate in your head as you read: purity, identity, content, activity and sterility. Many pages fold all of these into the purity percentage, which is where confusion starts. HPLC and MS are complementary tests with distinct scopes. A high purity figure describes the chromatographic signal; it says nothing on its own about how much net peptide is in the vial, whether the material is sterile, or whether it will behave as expected in a given experiment.

Why Must a COA Match the Exact Batch?

A COA is only directly relevant when its batch or lot number matches the peptide vial, the outer packaging and the supplier record exactly. Different production batches can return different analytical results, so a generic report, or a report from another lot, does not verify the material you are actually holding.

“Lot” and “batch” are usually used to mean the same thing: one defined quantity of material made in a single run under the same conditions. A report created for a previous synthesis, or for a different run of the same peptide, describes that run. It does not stand in for the batch on your bench, even when the product name is identical.

Here is what should line up before you trust the rest of the page: the product name, the strength or material description, the batch number, the physical form (such as lyophilised powder), the test date and the certificate or report reference. When all of those agree across the vial, the box and the COA, you have traceability. When one disagrees, you have a question to ask.

There are a few normal ways to verify a match: a vendor batch portal, a QR code that links to the batch COA, a report number you can quote to support, or a direct confirmation from the supplier. Transparency and traceability matter more than any single testing arrangement. A supplier who can pull the matching batch record on request is giving you something you can check.

Quick check: If the vial says ABX-BPC-2608-01 and the COA says ABX-BPC-2607-04, treat the report as documentation for another batch until the supplier provides the matching batch record.

You can see how we keep this traceable across our range of research peptides in the UK, where each product is documented as its own batch-specific record.

How Do You Verify a Peptide COA? A Seven-Step Checklist

Verify a peptide COA by matching the batch number, confirming the stated identity and material form, reviewing the HPLC trace and purity result, cross-checking the LC-MS mass data, checking the report date and laboratory details, reviewing any relevant supplementary tests, and confirming that the document can be independently traced.

1. Match the batch or lot number exactly. Compare the vial label, the outer packaging, the invoice or shipping paperwork where available, and the COA. This is a character-by-character check. A single wrong digit points to a different batch.
2. Confirm the peptide identity and material form. Check the name, the stated sequence or modification where shown, the molecular formula and mass, and the salt or counter-ion form. A COA for the free peptide and one for a salt form can list different masses for the same molecule.
3. Check the report is batch-specific and dated. Look for the batch number, a report number, the analysis date, a release date if included, the laboratory name, and a signatory or reviewer. A report with no date and no lab is hard to stand behind.
4. Review the HPLC chromatogram and reported purity. Look for a dominant target peak, visible integration, disclosed minor peaks, the purity result, and enough method context to understand it. A number with no chromatogram tells you less than a chromatogram with a number.
5. Review the LC-MS peptide identity evidence. Compare the expected mass with the observed mass. Raw mass-to-charge (m/z) values can look different from the molecular mass because peptide ions often carry more than one charge, so read the lab’s stated convention before calling a mismatch.
6. Assess supplementary tests only where reported. Water content, residual solvents, counter-ion content, endotoxin and microbial results should each carry a method, a unit, a value and a sample or batch identifier. A word like “passed” with no data is not a result.
7. Verify the record beyond a screenshot. Use a batch-verification portal, a QR route, a laboratory report number, or a direct supplier confirmation. Peptide batch verification shows up again and again in how researchers vet peptide COAs, so treat a checkable record as the baseline you should expect.

In one sentence, when you verify peptide COA data, the most useful report traces to your exact batch, explains how purity was measured, supports identity with mass data, and gives enough laboratory detail to check the record.

How to Read the Identity and Traceability Section of a Peptide COA

Before you read a single purity percentage, confirm that the certificate identifies the exact material, batch and analytical record. If those details are missing or do not match the supplied item, the rest of the COA carries limited evidential weight.

Product name and stated peptide identity

The report should name the compound clearly, and where relevant, show the sequence, analogue or modification. Similar names are a real trap in this field: a fragment, an acetylated version and a full-length parent peptide can read almost the same at a glance while being different molecules with different masses. Our BPC-157 research overview walks through one such pair, where a BPC-157 10 mg record and a TB-500 10 mg record each need their own batch-specific data. The sample name on the test record should match the product record you are checking.

Molecular formula, expected mass and peptide form

The theoretical mass, calculated from the stated composition, is your identity reference point for the MS section later. Two things trip people up here. First, molecular mass and reported m/z are not always the same number, because of charge states. Second, the salt or counter-ion form changes the mass: a peptide supplied as a trifluoroacetate (TFA) salt weighs more than the free peptide. And “10 mg of material” is not the same as “10 mg of net peptide” unless a content or assay result specifically says so, since salt, water and counter-ions all add mass.

Batch number, COA number and report dates

Four fields do four jobs, and it helps to read them separately:

• Batch number: the production or material identifier.
• COA or report number: the document identifier.
• Analysis date: when the testing happened.
• Release date: when the record was approved, if it is included.

A retest or expiry date should be read exactly as written. It is a stated date on a document, and it does not guarantee the material stays unchanged.

Storage and sample condition

Storage instructions give handling context, such as keeping lyophilised material cold and dry. The physical format is important here too, and our guide on peptide pens vs vials for research covers how presentation affects handling and documentation. A storage line describes what is recommended; it is not proof of how the vial was actually handled after it left the lab. Appearance can be informative, and an off colour or a collapsed cake is worth noticing, but appearance alone cannot prove identity or purity.

COA field	What it tells you	What to verify
Product name	The material described in the report	It matches the product label and listing
Batch/lot number	Which specific batch was tested	Exact match to vial and packaging
COA/report number	A unique document reference	It is present and usable for verification
Analysis date	When the tested sample was analysed	It is visible and plausible for the batch
Expected molecular mass	The reference value for MS review	It fits the named peptide and reported form
Sample form	How the material is described, such as lyophilised powder	It is consistent with the product information
Storage statement	The recommended storage conditions	It is specific, with real conditions stated

How Do You Read an HPLC Chromatogram on a Peptide COA?

An HPLC chromatogram shows detector response over time as the components of a peptide sample separate on a column. On a peptide chromatogram, look for a dominant target peak, the reported HPLC peptide purity calculation, visible minor peaks, clear integration, and enough method context (such as the detector wavelength) to understand how the result was produced.

What HPLC measures in peptide analysis

HPLC separates compounds by how strongly they interact with the column’s stationary phase and the liquid mobile phase moving through it. As each component leaves the column at a different time, the detector draws a chromatogram. For peptides, laboratories commonly use reversed-phase HPLC (RP-HPLC), usually on a C18 column with a water and acetonitrile gradient, though exact conditions vary by peptide and lab. According to Creative Proteomics, peptide RP-HPLC typically uses UV detection at 210 to 220 nm, the range where the peptide backbone absorbs. HPLC here gives you separation and a purity-related result. It does not make a claim about biological activity.

What the axes and peaks mean

• X-axis: retention time, how long a component takes to leave the column.
• Y-axis: detector response, how much signal the detector sees.
• A peak: the signal from a component eluting at its retention time.
• The main peak: the candidate signal for your target peptide.
• Minor peaks: possible impurities, related substances or other detected components, depending on the method.

How HPLC purity is commonly calculated

Most peptide COAs report purity by area normalisation. In plain terms:

HPLC area purity (%) = (area of the main peak ÷ total area of all integrated peaks) × 100.

The result is the share of the detected, integrated signal that belongs to the main peak under the stated conditions. Detector response can vary by compound and by wavelength, so this is a proportion of what the detector saw, measured the way the method defines it. That figure should not be read across as net peptide content, potency, biological activity, sterility or general safety. It is a chromatographic proportion, no more and no less.

Feature	What to look for	Why it matters
Main peak	A clear, dominant peak at a stated retention time	Supports the reported primary component
Minor peaks	Visible and integrated secondary signals	Shows whether impurity-related peaks are disclosed
Peak area	The percentage tied to the main peak	The basis of the reported HPLC purity
Baseline	A stable baseline before and after the peaks	Heavy noise or drift complicates interpretation
Peak shape	A reasonably defined peak	Broad, split or tailing peaks may need context
Peak integration	Clear boundaries and labelled values	Shows how the percentage was calculated
Method details	Wavelength, column, gradient or sample conditions	Helps you judge what the result represents

Why a large main peak is not the whole story

Two components can sometimes leave the column at almost the same time and stack into one apparent peak, a problem called co-elution. Different substances also do not all respond equally to a UV detector, so a small peak by area is not always a small amount by mass. And if a chromatogram is cropped, or shown with no integration marks, you simply cannot verify how the number was built. This is exactly why mass-spectrometry identity evidence belongs next to the HPLC data.

Why retention time alone does not prove identity

Retention time is a useful context, but it changes with the column, the mobile-phase mix, the gradient, the temperature, the flow rate and even the instrument. Two labs running the same peptide can report different retention times and both be correct. So a matching retention time supports identity; it does not prove it by itself. For that, you read the LC-MS section.

Figure 1. An example HPLC chromatogram on a peptide COA, showing the main peak, minor peaks, retention time, baseline and integrated area. Illustrative only.

What Does LC-MS Confirm on a Peptide COA?

LC-MS supports peptide identity by separating the components chromatographically and then measuring their mass-to-charge values. A good COA compares the expected peptide mass with an observed or deconvoluted mass result. This complements the HPLC purity figure, because a purity result alone does not confirm that the dominant peak is the intended peptide.

How LC-MS complements HPLC

HPLC separates the material and describes how it behaves on the column. Mass spectrometry measures the mass of the ions produced from it. LC-MS joins the two, putting mass data against the separated component as it elutes. Read together, they cover each other’s blind spots: HPLC supports the purity picture, and MS supports the molecular identity. This pairing matters because UV-HPLC is partly blind on its own. Salts, water and components that do not absorb UV light at the chosen wavelength can be near-invisible to the detector, so a purity percentage needs mass data (and, where relevant, water and counter-ion results) to sit alongside it.

Expected mass versus observed mass

The theoretical or expected mass is calculated from the peptide’s stated composition. The observed mass is what the instrument reports, often as an average or deconvoluted value. A clear report states which convention it is using, because comparing an average mass to a monoisotopic one, or an m/z to a molecular mass, can look like a mismatch when nothing is wrong. Method and calibration context help here, without needing to turn the COA into a textbook.

Why raw m/z may look different from the peptide mass

Electrospray ionisation, the technique commonly used, can put more than one charge on a single peptide. The raw spectrum then shows mass-to-charge (m/z) values, which read lower than the intact neutral mass. A peptide of around 3,000 Da might appear as a +2 or +3 ion at a much lower m/z. A deconvoluted value takes those multiple charge-state signals and works back to one estimated molecular mass. So before you conclude that an observed mass is wrong, check whether you are reading a raw m/z or a deconvoluted mass, and read the lab’s stated convention.

Figure 2. One peptide appears at several m/z values from different charge states; deconvolution resolves these to a single molecular mass to compare against the expected value.

What MS does not establish on its own

A correct mass is strong identity evidence, but it does not prove full chromatographic purity by itself. It may not separate every related impurity, isomer or co-eluting compound, and a loose mass tolerance can hide real problems. A tolerance quoted at roughly ±0.1% on a 3,000 Da peptide allows about ±3 Da of wiggle room, which is wide enough to mask a truncated sequence or a swapped residue. Full sequence confirmation, where it is needed, uses additional methods and reporting; do not assume it from a single mass match.

Question	HPLC can help address	LC-MS can help address
Is there a dominant chromatographic component?	Yes	Sometimes, when paired with LC separation
What proportion of the integrated signal is the main peak?	Yes	Not usually the primary purity metric
Does the main material have a mass consistent with the named peptide?	Not by itself	Yes, through observed or deconvoluted mass
Does the result prove biological activity?	No	No
Does the result prove sterility or human suitability?	No	No

Which Additional Peptide COA Tests Matter?

Extra results can strengthen a peptide COA when they are relevant to the material and clearly documented. Depending on the report, these may include water content, residual solvents, counter-ion content, endotoxin or microbial testing. Each result should name the method, the unit, the value and the tested batch. A broad claim with no data is not the same as an analytical result.

Test or field	What it may help assess	What a useful entry includes
Water content	Moisture in the tested material	Method, numerical result, units and batch identity
Residual solvents	Solvents that may remain after production	Listed analytes, result, units, method and any limit
Counter-ion content	The salt or counter-ion tied to the material form	Named counter-ion, method and basis of expression
Endotoxin	Bacterial endotoxin measurement, if performed	Method, numerical result, units, batch reference
Microbial test	Microbial status, if performed	Method, result, detection threshold and batch identity
Net peptide content / assay	The amount of stated peptide, if measured	Method, units, stated reference basis and result
Appearance	The visual description at testing	A clear sample description, though not a substitute for data

There is a wider point behind these entries. Credible analytical methods are built on principles that regulators lean on: specificity, accuracy, precision, detection and quantitation limits, linearity and range. You do not need to master validation science to use a COA. It helps, though, to see why a real report is more than one number: a value means something when the method behind it is sound and stated.

This is also where documented thresholds add useful perspective. The internationally agreed ICH Q3A(R2) guideline, applied in the UK through the Medicines and Healthcare products Regulatory Agency (MHRA), sets reference points for a new drug substance: an impurity above about 0.10% generally warrants identification, and one above about 0.15% needs qualification. Those are dose-dependent, pharmaceutical-manufacturing benchmarks, and research materials sit in a different context, so read them as a sense of scale for what “an impurity worth naming” can mean.

How to Check Whether a Peptide COA Is Credible

A polished PDF is not automatically a verifiable COA. Credibility comes from a specific batch connection, identifiable analytical methods, traceable report details, and an honest description of what the testing does and does not show.

Green flags on a peptide COA

• The batch or lot number matches your material exactly.
• The product name, material form and report reference are clearly stated.
• A named laboratory or analytical organisation appears on the report.
• Both an analysis date and a report date are present.
• The HPLC chromatogram is shown with integration and method details.
• Expected and observed MS data are given together.
• Any extra tests carry methods, units and numerical results.
• There is a batch-verification route or a supplier support process.
• The claims carefully separate purity, identity, content and sterility.

Red flags on a peptide COA

• A generic document with no lot or batch number.
• A report batch that differs from the vial or packaging.
• A headline purity claim with no chromatogram, method or date.
• Words like “tested” or “verified” with no numerical data behind them.
• An unnamed laboratory, or no report or certificate number.
• The same certificate reused across visibly different products or batches.
• A claim that 99% purity proves safety, dosing accuracy, sterility or performance.
• Endotoxin, residual-solvent or microbial claims with no method, result or unit.

One practical tell sits on top of that list. Suspiciously round purity numbers, such as an exact 99.00%, are unusual from real instruments, which tend to produce values with decimal detail like 98.73%. A round figure proves nothing by itself, though it is a fair prompt to ask for the chromatogram behind it.

Figure 3. A fast green-flag / red-flag credibility check for any peptide COA.

Common Mistakes When Reading a Peptide COA

Treating the highest purity percentage as the only thing that matters. A 99.2% figure with no chromatogram is weaker evidence than a 98.4% figure with a full, dated, integrated trace and matching mass data.

Ignoring a batch-number mismatch. If the COA batch and the vial batch differ, the report describes other material until the supplier provides the matching record.

Confusing HPLC purity with content. Area purity is a proportion of the detected signal. It is not a measure of how many milligrams of net peptide sit in the vial; that needs a content or assay result.

Treating retention time as identity proof. Retention time supports identity but shifts with the method and instrument, so it cannot stand alone.

Misreading a raw m/z as the full molecular mass. Multiply charged ions show lower m/z values; the deconvoluted mass is the figure to compare against the theoretical mass.

Assuming missing tests have passed. A test that is not on the report was not shown to you. Silence is not a result.

Treating “third-party tested” as meaningful on its own. The phrase means little without a named lab, a method and a traceable report you can actually check.

Making human-use or therapeutic assumptions from research documentation. A COA is a description of research material. It says nothing about human suitability, safety or outcomes.

Example: How to Review a Peptide COA Step by Step

The example below shows how one COA should be read as a connected evidence set: the batch match first, then identity, HPLC purity, LC-MS mass data, supplementary tests and traceability. It is illustrative and does not represent a real product, batch or laboratory report.

COA detail	Fictional example	What to check
Product name	Example Peptide X, 10 mg	Does it match the labelled product?
Batch number	ABL-EPX-260816	Does it match the vial, packaging and supplier record?
COA number	COA-EPX-816-01	Is it a unique, traceable document reference?
HPLC result	98.7% area purity	Are the chromatogram, integration and method supplied?
HPLC data	One dominant peak plus minor integrated peaks	Are the baseline, peaks and integration visible?
Expected mass	1,234.56 Da	Is the value compatible with the product identity and form?
Observed MS data	Deconvoluted mass reported near the expected value	Does the report state the mass convention and method?
Water content	Numerical result with method and units	Is the sample or batch identified?
Analysis date	14 August 2026	Is it visible and logically linked to this batch?
Verification	Supplier batch-record lookup	Can the record be traced beyond a generic PDF?

Reading it in order: 

• Step one, the batch. ABL-EPX-260816 on the COA has to equal the batch printed on the vial and box, character for character, before anything else counts. 
• Step two, identity: the name and form match the listing, and the expected mass of 1,234.56 Da becomes the reference for the MS check.
• Step three is HPLC purity. The 98.7% figure is only as good as the trace behind it, so you look for one dominant peak, disclosed minor peaks and clear integration, with the method noted.
• Step four is the mass data: the report gives a deconvoluted value near 1,234.56 Da and says so, which is why it lines up with the theoretical mass; a raw m/z would read lower.
• Step five is the supplementary result. The water-content entry lists a method, a number and units, tied to this batch, so it reads as a real measurement. 
• Step six, the date: 14 August 2026 sits logically with this batch and is recent enough to stay relevant. 
• Step seven, traceability: because the batch record can be looked up with the supplier, the whole document can be checked against a source you can reach.

In this hypothetical example, the report is more credible because the material, batch, HPLC record, mass data and document reference all connect. Even so, the record should not be read as proof of biological activity, sterility, human suitability or performance in any specific experiment.

Peptide COA FAQ

What is a peptide Certificate of Analysis?

A peptide COA is an analytical document tied to a defined material batch. It commonly records the product identity, the batch number, the methods used, the reported purity, mass-spectrometry information, dates and laboratory details. The exact data varies between reports, so a COA is only as useful as its traceability and method transparency allow.

Does HPLC purity prove peptide identity?

No, HPLC purity describes the chromatographic signal assigned to the main integrated peak under a stated method. It helps you judge sample composition, but it does not confirm on its own that the main peak is the intended peptide. LC-MS or MS mass data provides the complementary identity evidence you need.

Why is the batch number important on a peptide COA?

The batch number links the analytical report to one specific manufactured lot. If it does not match the vial or packaging exactly, the COA may describe a different sample or synthesis run. In that case it should not be treated as direct verification of the material you actually received.

What should I look for in an HPLC chromatogram?

Look for a dominant main peak, visible minor peaks, clear integration, a reported purity value, and method context such as detector wavelength, retention time or chromatographic conditions. A purity percentage with no chromatogram and no method behind it is far less informative than a transparent, fully shown trace.

What does LC-MS show on a peptide COA?

LC-MS combines chromatographic separation with mass-spectrometry data. It supports identity by comparing an expected peptide mass with the observed or deconvoluted result. Raw mass-to-charge values can look different from the full molecular mass, because peptide ions produced by electrospray ionisation often carry more than one charge.

Does a COA prove sterility or suitability for human use?

No, a standard COA does not prove sterility, endotoxin status, safety, biological activity or suitability for human use. Each of those needs its own specific testing, a documented scope and appropriate regulatory evaluation. A purity and identity record covers documentation quality for research material, nothing further.

Is 99% HPLC purity always better than 98%?

Not automatically. The method, the traceability, the chromatogram quality, the identity evidence and the type of impurities present all shape what a figure means. A stated percentage should be read in context, alongside the trace and the mass data, as one part of a complete quality picture.

Research peptides reach the bench in two main formats:

• A pre-filled pen is a sealed device holding the compound at a fixed concentration, ready to dispense in set increments with no mixing.
•  A lyophilised vial holds the same compound as a freeze-dried powder that you reconstitute with bacteriostatic water before use. 

This guide compares the two on what actually makes a difference in a lab: reproducibility, stability chemistry, and documentation. We have parked convenience and self-use to one side, because those miss the point for research work. Both formats are supplied for laboratory research use only and are not for human consumption.

Peptide Pens VS Vials – Quick Comparison

Take a look at the short version before we get into the science. The compound inside is identical; the table compares the handling pathway around it.

Factor	Pre-filled Pen	Lyophilised Vial
Preparation required	None, sealed and metered	Reconstitution with bacteriostatic water
Dosing/volume reproducibility	Fixed increments, low operator variance	Depends on manual draw precision
Sterility exposure	Single sealed device, minimal re-entry	Repeated needle entry raises contamination risk
Stability once prepared	Stable for device shelf life	Reconstituted solution degrades faster (days to weeks at 2 to 8°C)
Format flexibility	Fixed concentration	Adjustable concentration for custom protocols
Best suited for	Repeatable, multi-session protocols	Custom concentrations, calibration, bulk or cost-sensitive studies
Documentation	Easier batch and COA traceability per sealed unit	Requires logging reconstitution date, water lot, and dilution

What Each Format Actually Is

Both peptide pens and peptide vials carry the same peptide. What changes is the handling pathway from packaging to bench, and that pathway drives most of the differences below.

Pre-filled pens

A pre-filled pen is a sealed device with the peptide already held at a set concentration. A click-dial mechanism dispenses fixed increments per actuation, so there is no powder to mix and no concentration to calculate. Apexion supplies selected compounds in this ready-to-use pen format, and the Pen Priming Guide covers set-up for research handling.

Lyophilised vials

A lyophilised vial holds the peptide as a freeze-dried powder. Before use, you reconstitute it with bacteriostatic water, work out the resulting concentration, and draw your target volume. This is the traditional format for compounds like BPC-157 and TB-500, and it gives you full control over concentration.

The key point is that the molecule is the same in both. A vial and a pen of the same peptide differ only in the handling pathway around an identical compound.

Reproducibility and Measurement Variance

For research, the pen’s real advantage is reproducibility. A metered device dispenses the same set volume every actuation, so operator variance stays low. A vial protocol stacks several manual steps, and each one adds a little error that compounds across a study.

Walk through the vial pathway. You reconstitute the powder, calculate the concentration, translate your target into a volume, then draw to a mark on a syringe by eye. Every step carries a small measurement error, and those errors add up across dozens of draws in a multi-week study.

That variance lands in your inter-assay consistency and can blur a dose-response curve. Picture a 3% draw error repeated across twenty sessions: each draw looks fine on its own, yet together they widen your error bars and make a real effect harder to see. Reproducibility is a data-quality question first, and a convenience question a distant second.

Figure 1: How measurement error compounds across manual vial steps versus a metered pen.

Insulin pens are a different product, but they are the closest well-studied metered-device class, so they work as a precedent rather than peptide-specific data. Tested against the ISO 11608-1 standard, both pens in one study “delivered all doses within ISO limits”, showing that sealed metered devices hold tight tolerances across their range. Manual syringe draws, by contrast, lose accuracy fastest at very small volumes, exactly where fine research work often sits.

Stability Chemistry: Why Format Affects Shelf Life

Format decides how exposed your peptide is to the things that degrade it. A dry, sealed peptide is far more stable than the same peptide sitting in solution, so the handling pathway sets the real shelf life.

The gap is large. Peptide manufacturers advise keeping peptides as dry lyophilisate in a tightly closed container below minus 15°C, with minus 50°C or lower preferred for long-term storage, and notes that frozen solutions “may be kept for a few weeks.” So a dry peptide can hold for months to years, while the same peptide reconstituted is usually good for days to a few weeks at 2 to 8°C. Most of that loss happens early, in the first days after mixing.

Temperature drives the rate. As a rough rule of thumb from the Arrhenius relationship, every 10°C rise roughly doubles the rate of a degradation reaction. That is why a few minutes on a warm bench costs more than the fridge reading suggests, and why cold-chain discipline matters once a vial is open.

Light is also an important consideration. Peptides with aromatic residues, tryptophan, tyrosine and phenylalanine, absorb light and break down under it. A study on photosensitised oxidation found the “Trp residue yields N-formylkynurenine and hydroxytryptophan as oxidized products, whereas the Tyr undergoes dimerization” (Silva et al.). That is the chemistry behind amber and opaque packaging. Connect it back to format: a sealed pen standardises this exposure, while a reconstituted vial’s stability depends entirely on how it is handled afterward.

Two more enemies round out the set. Dry lyophilised peptide is hygroscopic, so it pulls in moisture from the air; Peptides manufacturers advise letting a sealed container reach room temperature in a desiccator before opening, which limits the water pickup that shortens shelf life. And repeated freeze-thaw cycles stress a peptide in solution and encourage aggregation, which is why aliquoting into single-use volumes is the safer habit.

Figure 2: The four enemies of peptide stability and the mechanism behind each.

Getting storage right is half the battle with any format. Our Precision Manufacturing page sets out how Apexion documents purity before a compound ever reaches your bench.

Contamination and Handling Risk

Every needle entry into a multi-use vial is a fresh chance for contamination and oxidation. Repeated septum punctures introduce air and microbes over the life of the vial, and each draw exposes more of the solution to oxygen. A sealed device, like a peptide pen, limits this by design.

Each puncture also pulls a little air into the headspace, and the dissolved oxygen that comes with it drives the slow oxidation of vulnerable residues over a vial’s working life. The fix for vials is disciplined handling. Best practice is to aliquot the reconstituted solution into single-use volumes, so you avoid repeated freeze-thaw cycles that stress the peptide and drive aggregation. Label each aliquot and store it cold.

Figure 3: Contamination and oxidation risk rises with each needle entry.

Some context could be helpful here. As researchers on the r/UK_Peptide_Sources community on Reddit point out, a pre-filled pen from a proper facility with cold-chain handling can be as clean as a well-managed vial; the contamination problems usually trace back to handling, not the format itself. A sealed, metered format reduces that handling risk, though it does not remove it entirely.

Documentation and Batch Traceability

This is where format choice shapes your records, and where most guides go quiet. Documentation is the ability to tie a specific measurement back to a specific batch, and the two formats make that job easier or harder.

Think of it as a traceability chain. With a sealed pen, one unit maps to one batch and one Certificate of Analysis (COA), so the chain is short and clean. With a vial, the chain has more links: the powder lot, the bacteriostatic water lot, the reconstitution date, and the dilution you used all sit between the raw material and the number in your notebook. Miss a link and the result is harder to defend.

Good records are what let another researcher, or you in six months, reproduce a result and trust it. When a number gets questioned, a clean chain back to a batch-specific COA is the difference between defending the finding and repeating the whole run.

For solid records with either format, log the batch or lot number, the reconstitution date and water source or lot for vials, and the storage conditions throughout. Apexion publishes the current COA on each product page, so the purity behind a given lot is documented on the page you order from. Products like GHK-Cu and SS-31 list HPLC-verified purity of at least 98 to 99%, in line with Apexion’s stated commitment to full transparency.

Figure 4: The traceability chain, sealed pen versus lyophilised vial.

When a Vial Is Still the Right Choice

A vial is the better pick in several common research situations:

• You need a custom or non-standard concentration the pen does not offer.
• You are working with a compound that no supplier offers in a pre-filled format.
• You are doing mass-spec calibration or analytical work that needs precise dilution control.
• You are running a larger-scale or cost-sensitive study where headline price per milligram matters.

For custom concentration work, a vial of CJC-1295 + Ipamorelin gives you the dilution control a fixed pen cannot.

When a Pre-Filled Pen Is the Right Choice

A pre-filled pen earns its place when consistency and clean handling lead your priorities:

• You are running a multi-session protocol that needs the same repeatable volume every time.
• You want to keep operator-introduced variance to a minimum across a study.
• You want to reduce open-vial handling and the contamination exposure that comes with it.

If a protocol runs for weeks and leans on tight repeatability, the metered pen format does the steady, boring work of giving you the same volume on session one and session twenty.

Comparison Summary / Decision Checklist

Use this quick decision aid to point yourself at the right format:

• Need a non-standard concentration? Choose a vial.
• Running a multi-week protocol that needs consistency? Choose a pre-filled format.
• Budget-constrained and high-volume? Choose a vial.
• Prioritising minimal handling steps and lower contamination exposure? Choose a pre-filled format.

Most labs end up using both, matching the format to the protocol in front of them.

Frequently Asked Questions

Is a peptide pen more accurate than a vial?

For repeatability, yes. A pen dispenses fixed increments with low operator variance, while a vial depends on manual reconstitution and syringe draws that add error at each step. Insulin-pen research on metered devices supports this, though it is an analogous device class rather than peptide-specific data.

How long does a reconstituted peptide stay stable?

Usually days to a few weeks at 2 to 8°C, with most degradation happening early. A dry, frozen peptide lasts far longer. To extend a solution’s life, aliquot it into single-use volumes and keep it cold and out of the light.

Can lyophilised peptides be frozen for long-term storage?

Yes. Bachem advises storing dry lyophilised peptide in a tightly closed container below minus 15°C, with minus 50°C or lower preferred for long-term storage. Keep the container sealed and let it reach room temperature in a desiccator before opening to limit moisture pickup.

Does format affect Certificate of Analysis traceability?

It does. A sealed pen maps one unit to one batch and one COA, a short chain. A vial adds links: powder lot, water lot, reconstitution date, and dilution. Logging each of these keeps a vial result traceable back to its batch-specific COA.

Which format is better for multi-week research protocols?

A pre-filled format usually suits multi-week work, because repeatable metered volumes hold consistency across many sessions and reduce handling. A vial still wins where the protocol needs custom concentrations or precise dilution control that a fixed pen cannot provide.

Disclaimer

All products and information referenced here are for laboratory research use only and are not for human consumption. This content is written for laboratory and analytical research audiences and is educational in nature. It does not constitute medical, clinical, or usage advice.